Poolbeg Pharma eyes Nasdaq listing in bid for $1bn sale

Poolbeg Pharma is planning to list on New York’s Nasdaq as chairman Cathal Friel eyes another $1bn exit for Raglan Capital investors.

he company is understood to be in discussions with advisors about an initial public offering (IPO) on the exchange, possibly by the end of the year, in a bid to ultimately attract a large trade buyer.

Source link

Denial of responsibility! planetcirculate is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.